Furthermore, some governments in Europe have explicitly asked clinicians not to prescribe GLP-1s for obesity and instead reserve them for people with Type 2 diabetes
WARNINGSConsult your physician prior to using this product if you are pregnant, nursing, under 18 years of age, taking medication or have a medical condition
semaglutide should be discontinued at least two months before a planned pregnancy During treatment , patients should: Attend all scheduled follow-up appointments to monitor both metabolic parameters and general wellbeing Keep a symptom diary noting any mood changes, particularly in the first three months of treatment Maintain open communication with healthcare providers about any concerns, however minor they may seem Continue existing mental health treatments unless specifically advised otherwise by a psychiatrist Adopt healthy lifestyle measures including regular physical activity, adequate sleep, and balanced nutrition, which support both metabolic and mental health Be aware that hypoglycaemia risk increases when GLP-1 agonists are used with insulin or sulfonylureas, and dose adjustments of these medications may be needed Common adverse effects of GLP-1 agonists include nausea, vomiting, diarrhoea, and constipation, which typically improve over time
Over an 18-month period, we work closely with employees to reinforce healthy habits like proper nutrition and regular exercise and provide behavioral coaching to gradually reduce their reliance on these medications
